{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T04:11:06Z","timestamp":1771042266500,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The cellular adhesion pathway has been suggested as playing an important role in the pathogenesis of atrial fibrillation (AF). However, prior studies that have investigated the role of adhesion pathway proteins in risk of AF have been limited in the number of proteins that were studied and in the ethnic and racial diversity of the study population. Therefore we aimed to study the associations of fifteen adhesion pathway proteins with incident AF in a large, diverse population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Multi-Ethnic Study of Atherosclerosis participants from four races\/ethnicities (n\u2009=\u20092504) with protein levels measured were followed for incident AF (n\u2009=\u2009253). HGF protein was measured on Exam 1 samples (N\u2009=\u20096669; AF n\u2009=\u2009851). Cox proportional hazards regression was used to assess the association of AF with 15 adhesion pathway proteins. Bonferroni correction was applied to account for multiple comparisons.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After adjusting for potential confounding variables (age, sex, race\/ethnicity, height, body mass index, systolic blood pressure, antihypertension therapy, diabetes status, current smoker, current alcohol use, and total and HDL cholesterol), and accounting for multiple testing (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05\/15\u2009=\u20090.0033), circulating levels of the following proteins were positively associated with a higher risk of AF: MMP-2 (HR per standard deviation increment, 1.27; 95% CI 1.11\u20121.45), TIMP-2 (HR 1.28; 95% CI 1.12\u20121.46), VCAM-1 (HR 1.32; 95% CI 1.16\u20121.50), and SLPI (HR 1.22; 95% CI 1.07\u20121.38). The association between proteins and AF did not differ by race\/ethnicity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Circulating levels of MMP-2, TIMP-2, VCAM-1, and SLPI were positively associated with an increased risk of incident AF in a diverse population. Our findings suggest that adhesion pathway proteins may be important risk predictors of AF.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-021-02241-w","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T17:02:51Z","timestamp":1631638971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Adhesion pathway proteins and risk of atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis"],"prefix":"10.1186","volume":"21","author":[{"given":"Israel J.","family":"Mendez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila M.","family":"Manemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas B.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi Q.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan R.","family":"Heckbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James S.","family":"Pankow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Y.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzette J.","family":"Bielinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,14]]},"reference":[{"issue":"10","key":"2241_CR1","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","volume":"98","author":"EJ Benjamin","year":"1998","unstructured":"Benjamin EJ, Wolf PA, D\u2019Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946\u201352.","journal-title":"Circulation"},{"issue":"10","key":"2241_CR2","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146\u2013603.","journal-title":"Circulation"},{"issue":"21","key":"2241_CR3","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.jacc.2007.06.054","volume":"50","author":"TT Issac","year":"2007","unstructured":"Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol. 2007;50(21):2021\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"2241_CR4","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.jacc.2012.04.063","volume":"60","author":"Y Guo","year":"2012","unstructured":"Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012;60(22):2263\u201370.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2241_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/eurheartj\/ehi645","volume":"27","author":"CJ Boos","year":"2006","unstructured":"Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J. 2006;27(2):136\u201349.","journal-title":"Eur Heart J"},{"issue":"1","key":"2241_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.amjcard.2009.02.053","volume":"104","author":"RB Schnabel","year":"2009","unstructured":"Schnabel RB, Larson MG, Yamamoto JF, Kathiresan S, Rong J, Levy D, et al. Relation of multiple inflammatory biomarkers to incident atrial fibrillation. Am J Cardiol. 2009;104(1):92\u20136.","journal-title":"Am J Cardiol"},{"issue":"14","key":"2241_CR7","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1093\/eurheartj\/ehq146","volume":"31","author":"D Conen","year":"2010","unstructured":"Conen D, Ridker PM, Everett BM, Tedrow UB, Rose L, Cook NR, et al. A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J. 2010;31(14):1730\u20136.","journal-title":"Eur Heart J"},{"issue":"5","key":"2241_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jamacardio.2017.0064","volume":"2","author":"K Willeit","year":"2017","unstructured":"Willeit K, Pechlaner R, Willeit P, Skroblin P, Paulweber B, Schernthaner C, et al. Association between vascular cell adhesion molecule 1 and atrial fibrillation. JAMA Cardiol. 2017;2(5):516\u201323.","journal-title":"JAMA Cardiol"},{"issue":"3","key":"2241_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ijcard.2010.04.033","volume":"150","author":"H Verdejo","year":"2011","unstructured":"Verdejo H, Roldan J, Garcia L, Del Campo A, Becerra E, Chiong M, et al. Systemic vascular cell adhesion molecule-1 predicts the occurrence of post-operative atrial fibrillation. Int J Cardiol. 2011;150(3):270\u20136.","journal-title":"Int J Cardiol"},{"key":"2241_CR10","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.12659\/MSM.895715","volume":"22","author":"SL Diao","year":"2016","unstructured":"Diao SL, Xu HP, Zhang B, Ma BX, Liu XL. Associations of MMP-2, BAX, and Bcl-2 mRNA and protein expressions with development of atrial fibrillation. Med Sci Monit. 2016;22:1497\u2013507.","journal-title":"Med Sci Monit"},{"issue":"9","key":"2241_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/aje\/kwf113","volume":"156","author":"DE Bild","year":"2002","unstructured":"Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol. 2002;156(9):871\u201381.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"2241_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"6","key":"2241_CR13","first-page":"1565","volume":"92","author":"PK Shah","year":"1995","unstructured":"Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation. 1995;92(6):1565\u20139.","journal-title":"Circulation"},{"issue":"5","key":"2241_CR14","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/01.CIR.0000136995.83451.1D","volume":"110","author":"N Auge","year":"2004","unstructured":"Auge N, Maupas-Schwalm F, Elbaz M, Thiers JC, Waysbort A, Itohara S, et al. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin\/ceramide pathway and smooth muscle cell proliferation. Circulation. 2004;110(5):571\u20138.","journal-title":"Circulation"},{"issue":"10","key":"2241_CR15","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1161\/01.CIR.96.10.3555","volume":"96","author":"RD Kenagy","year":"1997","unstructured":"Kenagy RD, Hart CE, Stetler-Stevenson WG, Clowes AW. Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. Circulation. 1997;96(10):3555\u201360.","journal-title":"Circulation"},{"issue":"3","key":"2241_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.CIR.0000109495.02213.52","volume":"109","author":"J Xu","year":"2004","unstructured":"Xu J, Cui G, Esmailian F, Plunkett M, Marelli D, Ardehali A, et al. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation. 2004;109(3):363\u20138.","journal-title":"Circulation"},{"issue":"11","key":"2241_CR17","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00392-011-0337-9","volume":"100","author":"JR Ehrlich","year":"2011","unstructured":"Ehrlich JR, Kaluzny M, Baumann S, Lehmann R, Hohnloser SH. Biomarkers of structural remodelling and endothelial dysfunction for prediction of cardiovascular events or death in patients with atrial fibrillation. Clin Res Cardiol. 2011;100(11):1029\u201336.","journal-title":"Clin Res Cardiol"},{"issue":"6","key":"2241_CR18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cjca.2015.08.001","volume":"32","author":"Y Liu","year":"2016","unstructured":"Liu Y, Xu B, Wu N, Xiang Y, Wu L, Zhang M, et al. Association of MMPs and TIMPs with the occurrence of atrial fibrillation: a systematic review and meta-analysis. Can J Cardiol. 2016;32(6):803\u201313.","journal-title":"Can J Cardiol"},{"issue":"9","key":"2241_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1540-8167.2011.02059.x","volume":"22","author":"Y Okumura","year":"2011","unstructured":"Okumura Y, Watanabe I, Nakai T, Ohkubo K, Kofune T, Kofune M, et al. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence. J Cardiovasc Electrophysiol. 2011;22(9):987\u201393.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"2241_CR20","first-page":"581","volume":"232","author":"M Hammwohner","year":"2007","unstructured":"Hammwohner M, Ittenson A, Dierkes J, Bukowska A, Klein HU, Lendeckel U, et al. Platelet expression of CD40\/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation. Exp Biol Med (Maywood). 2007;232(4):581\u20139.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"8","key":"2241_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1046\/j.1444-0903.2003.00378.x","volume":"33","author":"SA Hope","year":"2003","unstructured":"Hope SA, Meredith IT. Cellular adhesion molecules and cardiovascular disease. Part I. Their expression and role in atherogenesis. Intern Med J. 2003;33(8):380\u20136.","journal-title":"Intern Med J"},{"issue":"7","key":"2241_CR22","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1161\/CIRCRESAHA.107.166405","volume":"103","author":"A Bedel","year":"2008","unstructured":"Bedel A, Negre-Salvayre A, Heeneman S, Grazide MH, Thiers JC, Salvayre R, et al. E-cadherin\/beta-catenin\/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein. Circ Res. 2008;103(7):694\u2013701.","journal-title":"Circ Res"},{"issue":"5","key":"2241_CR23","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1172\/JCI119254","volume":"99","author":"Y Zhang","year":"1997","unstructured":"Zhang Y, DeWitt DL, McNeely TB, Wahl SM, Wahl LM. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J Clin Invest. 1997;99(5):894\u2013900.","journal-title":"J Clin Invest"},{"issue":"4","key":"2241_CR24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1600-6143.2008.02158.x","volume":"8","author":"S Schneeberger","year":"2008","unstructured":"Schneeberger S, Hautz T, Wahl SM, Brandacher G, Sucher R, Steinmassl O, et al. The effect of secretory leukocyte protease inhibitor (SLPI) on ischemia\/reperfusion injury in cardiac transplantation. Am J Transplant. 2008;8(4):773\u201382.","journal-title":"Am J Transplant"},{"issue":"1","key":"2241_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1046\/j.1365-2249.2000.01269.x","volume":"121","author":"C Sano","year":"2000","unstructured":"Sano C, Shimizu T, Sato K, Kawauchi H, Tomioka H. Effects of secretory leucocyte protease inhibitor on the production of the anti-inflammatory cytokines, IL-10 and transforming growth factor-beta (TGF-beta), by lipopolysaccharide-stimulated macrophages. Clin Exp Immunol. 2000;121(1):77\u201385.","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"2241_CR26","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/80489","volume":"6","author":"GS Ashcroft","year":"2000","unstructured":"Ashcroft GS, Lei K, Jin W, Longenecker G, Kulkarni AB, Greenwell-Wild T, et al. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med. 2000;6(10):1147\u201353.","journal-title":"Nat Med"},{"issue":"2","key":"2241_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/rr18","volume":"1","author":"JM Sallenave","year":"2000","unstructured":"Sallenave JM. The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor\/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. Respir Res. 2000;1(2):87\u201392.","journal-title":"Respir Res"},{"issue":"5","key":"2241_CR28","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/1043-4666(90)90062-X","volume":"2","author":"LA Rubin","year":"1990","unstructured":"Rubin LA, Galli F, Greene WC, Nelson DL, Jay G. The molecular basis for the generation of the human soluble interleukin 2 receptor. Cytokine. 1990;2(5):330\u20136.","journal-title":"Cytokine"},{"key":"2241_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev.immunol.26.021607.090357","volume":"26","author":"TR Malek","year":"2008","unstructured":"Malek TR. The biology of interleukin-2. Annu Rev Immunol. 2008;26:453\u201379.","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"2241_CR30","first-page":"1395","volume":"78","author":"S Mine","year":"1998","unstructured":"Mine S, Tanaka Y, Suematu M, Aso M, Fujisaki T, Yamada S, et al. Hepatocyte growth factor is a potent trigger of neutrophil adhesion through rapid activation of lymphocyte function-associated antigen-1. Lab Invest. 1998;78(11):1395\u2013404.","journal-title":"Lab Invest"},{"issue":"3","key":"2241_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1440-1681.2004.03970.x","volume":"31","author":"H Katoh","year":"2004","unstructured":"Katoh H, Shimada T, Inoue S, Takahashi N, Shimizu H, Ohta Y, et al. Reduced high serum hepatocyte growth factor levels after successful cardioversion in patients with atrial fibrillation. Clin Exp Pharmacol Physiol. 2004;31(3):145\u201351.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"15","key":"2241_CR32","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/heartjnl-2016-310450","volume":"103","author":"SJ Bielinski","year":"2017","unstructured":"Bielinski SJ, Berardi C, Decker PA, Larson NB, Bell EJ, Pankow JS, et al. Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease. Heart. 2017;103(15):1185\u201393.","journal-title":"Heart"},{"issue":"11","key":"2241_CR33","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1161\/STROKEAHA.116.014172","volume":"47","author":"EJ Bell","year":"2016","unstructured":"Bell EJ, Larson NB, Decker PA, Pankow JS, Tsai MY, Hanson NQ, et al. Hepatocyte growth factor is positively associated with risk of stroke: the MESA (Multi-Ethnic Study of Atherosclerosis). Stroke. 2016;47(11):2689\u201394.","journal-title":"Stroke"},{"issue":"5","key":"2241_CR34","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3892\/etm.2013.1274","volume":"6","author":"M Li","year":"2013","unstructured":"Li M, Yi X, Ma L, Zhou Y. Hepatocyte growth factor and basic fibroblast growth factor regulate atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease via the mitogen-activated protein kinase signaling pathway. Exp Ther Med. 2013;6(5):1121\u20136.","journal-title":"Exp Ther Med"},{"issue":"4","key":"2241_CR35","first-page":"1222","volume":"83","author":"A De Bellis","year":"1998","unstructured":"De Bellis A, Di Martino S, Fiordelisi F, Muccitelli VI, Sinisi AA, Abbate GF, et al. Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves\u2019 disease patients followed up for development of ophthalmopathy. J Clin Endocrinol Metab. 1998;83(4):1222\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2241_CR36","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1212\/WNL.48.6.1557","volume":"48","author":"G Giovannoni","year":"1997","unstructured":"Giovannoni G, Lai M, Thorpe J, Kidd D, Chamoun V, Thompson AJ, et al. Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging. Neurology. 1997;48(6):1557\u201365.","journal-title":"Neurology"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02241-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-021-02241-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02241-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T17:04:30Z","timestamp":1631639070000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-02241-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2241"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-02241-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]},"assertion":[{"value":"22 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the participants gave written informed consent, and the MESA study protocol and its ancillary studies received approval by the appropriate ethics committees: the University of Minnesota Institutional Review Board (IRB # IRB00000438), Wake Forest University IRB (# IRB00008492), Columbia University IRB (# IRB00002973), Johns Hopkins University IRB (# 00001656), Northwestern University IRB (# IRB00005003), University of California Los Angeles IRB (# 00000172), University of Washington IRB (# IRB00005647). The study was done in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"436"}}